Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism

Abstract Background Bone marrow mesenchymal stem cell-derived extracellular vesicles (BMSC-EVs) have been highly studied with their critical roles as carriers of therapeutic targets such as microRNAs (miRNAs) in the treatment of human diseases, including pulmonary arterial hypertension (PAH). Herein...

Full description

Bibliographic Details
Main Authors: Mengzhi Wan, Caiju Lu, Yu Liu, Feng Luo, Jing Zhou, Fei Xu
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-023-02474-7
_version_ 1797556937281241088
author Mengzhi Wan
Caiju Lu
Yu Liu
Feng Luo
Jing Zhou
Fei Xu
author_facet Mengzhi Wan
Caiju Lu
Yu Liu
Feng Luo
Jing Zhou
Fei Xu
author_sort Mengzhi Wan
collection DOAJ
description Abstract Background Bone marrow mesenchymal stem cell-derived extracellular vesicles (BMSC-EVs) have been highly studied with their critical roles as carriers of therapeutic targets such as microRNAs (miRNAs) in the treatment of human diseases, including pulmonary arterial hypertension (PAH). Herein, we tried to study the potential of BMSC-EVs to deliver miR-200b for the regulation of macrophage polarization in PAH. Methods Rat models of PAH were induced with monocrotaline treatment, followed by miR-200b expression detection in lung tissues, pulmonary artery smooth muscle cells (PASMCs) and macrophages. miR-200b-containing BMSCs or miR-200b-deficient BMSCs were selected to extract EVs. Then, we assessed the changes in rats with PAH-associated disorders as well as in vitro macrophage polarization and the functions of PASMCs after treatment with BMSC-EVs. Moreover, the interaction between miR-200b, phosphodiesterase 1 A (PDE1A) was identified with a luciferase assay, followed by an exploration of the downstream pathway, cAMP-dependent protein kinase (PKA). Results miR-200b was reduced in lung tissues, PASMCs and macrophages of rats with PAH-like pathology. BMSC-EVs transferred miR-200b into macrophages, and subsequently accelerated their switch to the M2 phenotype and reversed the PAH-associated disorders. Furthermore, miR-200b carried by BMSC-EVs induced PKA phosphorylation by targeting PDE1A, thereby expediting macrophage polarization. Conclusion Our current study highlighted the inhibitory role of BMSC-EV-miR-200b in PAH formation.
first_indexed 2024-03-10T17:10:14Z
format Article
id doaj.art-889d4e02780f419eac8597ad4cf5e411
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-03-10T17:10:14Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-889d4e02780f419eac8597ad4cf5e4112023-11-20T10:40:46ZengBMCRespiratory Research1465-993X2023-09-0124111710.1186/s12931-023-02474-7Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanismMengzhi Wan0Caiju Lu1Yu Liu2Feng Luo3Jing Zhou4Fei Xu5Department of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang UniversityDepartment of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang UniversityDepartment of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang UniversityDepartment of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang UniversityDepartment of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang UniversityDepartment of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang UniversityAbstract Background Bone marrow mesenchymal stem cell-derived extracellular vesicles (BMSC-EVs) have been highly studied with their critical roles as carriers of therapeutic targets such as microRNAs (miRNAs) in the treatment of human diseases, including pulmonary arterial hypertension (PAH). Herein, we tried to study the potential of BMSC-EVs to deliver miR-200b for the regulation of macrophage polarization in PAH. Methods Rat models of PAH were induced with monocrotaline treatment, followed by miR-200b expression detection in lung tissues, pulmonary artery smooth muscle cells (PASMCs) and macrophages. miR-200b-containing BMSCs or miR-200b-deficient BMSCs were selected to extract EVs. Then, we assessed the changes in rats with PAH-associated disorders as well as in vitro macrophage polarization and the functions of PASMCs after treatment with BMSC-EVs. Moreover, the interaction between miR-200b, phosphodiesterase 1 A (PDE1A) was identified with a luciferase assay, followed by an exploration of the downstream pathway, cAMP-dependent protein kinase (PKA). Results miR-200b was reduced in lung tissues, PASMCs and macrophages of rats with PAH-like pathology. BMSC-EVs transferred miR-200b into macrophages, and subsequently accelerated their switch to the M2 phenotype and reversed the PAH-associated disorders. Furthermore, miR-200b carried by BMSC-EVs induced PKA phosphorylation by targeting PDE1A, thereby expediting macrophage polarization. Conclusion Our current study highlighted the inhibitory role of BMSC-EV-miR-200b in PAH formation.https://doi.org/10.1186/s12931-023-02474-7Extracellular vesiclesBone marrow mesenchymal stem cellsPulmonary arterial hypertensionmicroRNA-200bMacrophage polarizationLuciferase
spellingShingle Mengzhi Wan
Caiju Lu
Yu Liu
Feng Luo
Jing Zhou
Fei Xu
Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism
Respiratory Research
Extracellular vesicles
Bone marrow mesenchymal stem cells
Pulmonary arterial hypertension
microRNA-200b
Macrophage polarization
Luciferase
title Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism
title_full Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism
title_fullStr Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism
title_full_unstemmed Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism
title_short Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism
title_sort mesenchymal stem cell derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microrna 200b dependent mechanism
topic Extracellular vesicles
Bone marrow mesenchymal stem cells
Pulmonary arterial hypertension
microRNA-200b
Macrophage polarization
Luciferase
url https://doi.org/10.1186/s12931-023-02474-7
work_keys_str_mv AT mengzhiwan mesenchymalstemcellderivedextracellularvesiclespreventtheformationofpulmonaryarterialhypertensionthroughamicrorna200bdependentmechanism
AT caijulu mesenchymalstemcellderivedextracellularvesiclespreventtheformationofpulmonaryarterialhypertensionthroughamicrorna200bdependentmechanism
AT yuliu mesenchymalstemcellderivedextracellularvesiclespreventtheformationofpulmonaryarterialhypertensionthroughamicrorna200bdependentmechanism
AT fengluo mesenchymalstemcellderivedextracellularvesiclespreventtheformationofpulmonaryarterialhypertensionthroughamicrorna200bdependentmechanism
AT jingzhou mesenchymalstemcellderivedextracellularvesiclespreventtheformationofpulmonaryarterialhypertensionthroughamicrorna200bdependentmechanism
AT feixu mesenchymalstemcellderivedextracellularvesiclespreventtheformationofpulmonaryarterialhypertensionthroughamicrorna200bdependentmechanism